Richard Nolan Townsend, Chief Executive Officer at Lexeo Therapeutics, Inc. (LXEO), sold 25,947 shares at $4.48 ($116K) on 2026-07-01, disclosed to the SEC on 2026-07-01.
Open-market sale of $116k LXEO by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| LXEO | SELL | 2026-04-07 | $313K | — | Filing → |
| LXEO | SELL | 2026-02-20 | $65K | — | Filing → |
| LXEO | SELL | 2025-11-20 | $10K | — | Filing → |